These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8004109)

  • 1. Point mutations of the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy.
    Ionasescu V; Searby C; Ionasescu R
    Hum Mol Genet; 1994 Feb; 3(2):355-8. PubMed ID: 8004109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting the pathogenic mechanism of the GJB1 5' UTR c.-103C > T mutation causing CMTX1.
    Grosz BR; Svaren J; Perez-Siles G; Nicholson GA; Kennerson ML
    Neurogenetics; 2021 Jul; 22(3):149-160. PubMed ID: 34089394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered trafficking of mutant connexin32.
    Deschênes SM; Walcott JL; Wexler TL; Scherer SS; Fischbeck KH
    J Neurosci; 1997 Dec; 17(23):9077-84. PubMed ID: 9364054
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Niu J; Dai Y; Liu M; Li Y; Ding Q; Guan Y; Cui L; Jin L
    Front Neurol; 2019; 10():1406. PubMed ID: 32010055
    [No Abstract]   [Full Text] [Related]  

  • 5. X-linked dominant Charcot-Marie-Tooth neuropathy (CMTX): new mutations in the connexin32 gene.
    Ressot C; Latour P; Blanquet-Grossard F; Sturtz F; Duthel S; Battin J; Corbillon E; Ollagnon E; Serville F; Vandenberghe A; Dautigny A; Pham-Dinh D
    Hum Genet; 1996 Aug; 98(2):172-5. PubMed ID: 8698335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1).
    Fairweather N; Bell C; Cochrane S; Chelly J; Wang S; Mostacciuolo ML; Monaco AP; Haites NE
    Hum Mol Genet; 1994 Jan; 3(1):29-34. PubMed ID: 8162049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment.
    Xia JH; Liu CY; Tang BS; Pan Q; Huang L; Dai HP; Zhang BR; Xie W; Hu DX; Zheng D; Shi XL; Wang DA; Xia K; Yu KP; Liao XD; Feng Y; Yang YF; Xiao JY; Xie DH; Huang JZ
    Nat Genet; 1998 Dec; 20(4):370-3. PubMed ID: 9843210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connexin mutations in X-linked Charcot-Marie-Tooth disease.
    Bergoffen J; Scherer SS; Wang S; Scott MO; Bone LJ; Paul DL; Chen K; Lensch MW; Chance PF; Fischbeck KH
    Science; 1993 Dec; 262(5142):2039-42. PubMed ID: 8266101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connexins 26, 32 and 43 are expressed in virgin, pregnant and lactating mammary glands.
    Pérez-Armendariz EM; Luna J; Aceves C; Tápia D
    Dev Growth Differ; 1995 Aug; 37(4):421-431. PubMed ID: 37281114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Spectrum of Inherited Neuropathies in India.
    Sharma S; Govindaraj P; Chickabasaviah YT; Siram R; Shroti A; Seshagiri DV; Debnath M; Bindu PS; Taly AB; Nagappa M
    Ann Indian Acad Neurol; 2022; 25(3):407-416. PubMed ID: 35936615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and Treatments in Demyelinating CMT.
    Fridman V; Saporta MA
    Neurotherapeutics; 2021 Oct; 18(4):2236-2268. PubMed ID: 34750751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of connexins in breast cancer: from misregulated cell communication to aberrant intracellular signaling.
    Unal YC; Yavuz B; Ozcivici E; Mese G
    Tissue Barriers; 2022 Jan; 10(1):1962698. PubMed ID: 34355641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies targeting connexins.
    Laird DW; Lampe PD
    Nat Rev Drug Discov; 2018 Dec; 17(12):905-921. PubMed ID: 30310236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetics of neuropathies].
    Gess B; Schirmacher A; Young P
    Nervenarzt; 2013 Feb; 84(2):157-65. PubMed ID: 23325310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charcot-Marie-Tooth disease and intracellular traffic.
    Bucci C; Bakke O; Progida C
    Prog Neurobiol; 2012 Dec; 99(3):191-225. PubMed ID: 22465036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gap junctions in inherited human disease.
    Zoidl G; Dermietzel R
    Pflugers Arch; 2010 Jul; 460(2):451-66. PubMed ID: 20140684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cataracts are caused by alterations of a critical N-terminal positive charge in connexin50.
    Thomas BC; Minogue PJ; Valiunas V; Kanaporis G; Brink PR; Berthoud VM; Beyer EC
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2549-56. PubMed ID: 18326694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connexins and apoptotic transformation.
    Kalvelyte A; Imbrasaite A; Bukauskiene A; Verselis VK; Bukauskas FF
    Biochem Pharmacol; 2003 Oct; 66(8):1661-72. PubMed ID: 14555247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-channel SCAM identifies pore-lining residues in the first extracellular loop and first transmembrane domains of Cx46 hemichannels.
    Kronengold J; Trexler EB; Bukauskas FF; Bargiello TA; Verselis VK
    J Gen Physiol; 2003 Oct; 122(4):389-405. PubMed ID: 12975451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease.
    Abrams CK; Bennett MV; Verselis VK; Bargiello TA
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3980-4. PubMed ID: 11891346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.